The world has a message, but we're not going to like it
We might have the ability to cure someone, but that doesn't necessarilymean we'll be able to afford it It's always exciting to hear about the things that medical science ismaking possible. Custom-designed pharmaceuticals, high-tech artificial heartpumps and miracle cancer treatments make for compelling headlines, and theoptimism is justified-at least somewhat.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
